Research

Toxicology, Preclinical drug development, Regulatory Science

Interests

I have been involved in preclinical development of new medicines for 30 years and have signed off several hundred trials in the UK that were the first time a new drug was used in humans. My interest is to determine the extent to which drug development without animals can be optimised.